Concepedia

Paolo Tundo

PT

Statistics

Publications

16

Citations

555

H-Index

14

Active since

2002

Affiliations

University of Bari Aldo Moro(Current)

University of Foggia

University of Milan

Istituti di Ricovero e Cura a Carattere Scientifico

The Royal Free Hospital

Paolo Tundo is an author at University of Bari Aldo Moro specializing in antiviral therapy, infectious diseases, and pharmacy.

Publications per year

2002–2021

16

Publications

16

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Maria Carmela Piccirillo, Paolo A. Ascierto, Carlo Salvarani et al. · Journal of Translational Medicine · 2020 · 112 citations · Full text

, , +15

Virologic and Immunologic Response to Regimens Containing Nevirapine or Efavirenz in Combination with 2 Nucleoside Analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) Study

Alessandro Cozzi‐Lepri, Andrew Phillips, Antonella d’Arminio Monforte et al. · The Journal of Infectious Diseases · 2002 · 90 citations · Full text

, , +14

Interruption of Highly Active Antiretroviral Therapy in HIV Clinical Practice

Antonella d’Arminio Monforte, Alessandro Cozzi‐Lepri, Andrew Phillips et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 51 citations · Full text

, , +15

Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin

Teresa Santantonio, M. Fasano, Evangelista Sagnelli et al. · Hepatology · 2014 · 42 citations · Full text

, , +17

Real‐life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study

Marcello Persico, Andrea Aglitti, Michele Stanislaw Milella et al. · Liver International · 2019 · 36 citations

, , +15

1–5 of 16